Eurazeo

Kurma Partners, part of Eurazeo, announces the sale of ImCheck Therapeutics to Ipsen for an initial amount of €350 million, which could reach up to €1 billion depending on future milestones.   Founded in 2015 and supported since inception by Kurma, ImCheck Therapeutics develops a new generation of antibodies targeting various solid and hematologic cancers. This operation reflects the depth of Eurazeo’s healthcare expertise and our long-term commitment to supporting scientific innovation and industrial growth in Europe.   With Kurma, Eurazeo continues to strengthen its position as a leading investor in life sciences: financing and scaling the next generation of European healthcare champions.   Congratulations to the Kurma teams and ImCheck for this major achievement. William Kadouch-Chassaing Pierre d'Epenoux Rémi Droller Daniel Olive Matthieu Baret Benoist Grossmann Damien Fietta Gaston Samele Louis Bô Adin Huseljic CNRS Institut Paoli-Calmettes

3 of LinkedIn’s 20 most promising startups are part of Eurazeo’s portfolio: Mistral AI, Electra, and Flowdesk. Another proof that European tech has what it takes and that the best startups grow here. https://lnkd.in/ddFSKxKi Matthieu Baret Benoist Grossmann Louis Bô Laurent Chatelin Melissa Cohen Martin Sichelkow

👏 We're proud for our Growth team to have led the $100 million Series C round of Dexory, a leading provider of real-time warehouse visibility, intelligence and autonomous solutions. ➡️ Since its Series B, Dexory has scaled the reach of its AI-enabled data-intelligence platform DexoryView across Europe, North America and APAC. Dexory's platform delivers highly accurate real time operational insights to warehouses for customers such as GXO, Maersk, DHL, Stellantis and GE Appliances, unlocking efficiency, visibility and scalability at global scale. This new round will accelerate the product roadmap and global footprint, with Australia having been just launched, supporting the transformation of warehouses and supply chains worldwide. We're really excited to back Dexory as they transform practices and drive industries forward. Raluca Ragab Hala Fadel Anne-Charlotte Philbert Romain MOMBERT Alexandra Pederzani Maud Gillot

Comment investir dans le non coté quand on débute ?   Christophe BAVIERE partage 2 conseils simples pour franchir le pas avec discernement. D’abord, combiner private equity et private debt : la dette apporte un rendement régulier, le capital génère de la performance dans la durée. Ensuite, privilégier la diversification : choisir des fonds exposés à un large portefeuille d’entreprises, pour mieux répartir le risque et capter tout le potentiel de cette classe d’actifs.   👉 Plus d’infos sur notre espace Wealth : https://lnkd.in/e-CvNYnH

Quand votre épargne soutient l’innovation et la réindustrialisation européenne… et allège vos impôts. Avec le FCPI Ambition Europe 2025, les particuliers peuvent bénéficier d’une réduction d’impôt sur le revenu allant jusqu’à 25%, tout en orientant leur épargne vers des secteurs stratégiques pour l’avenir de l’Europe : technologie & IA, défense & souveraineté, santé... Concrètement, ce fonds finance des PME françaises et européennes à taille humaine, dans leur croissance, leur R&D ou leur internationalisation. Derrière, ce sont des histoires d’entrepreneurs qui bâtissent l’avenir : Mistral AI (le ChatGPT français), LegalPlace (déjà une création d’entreprise sur six), MATERRUP Ciments bas carbone, Electra (le réseau de bornes de recharge ultra-rapides)…    En bref, un fonds qui finance transforme l’impôt en moteur de compétitivité européenne.  Les fonds de placement présentent un risque de perte en capital. Les performances passées ne préjugent pas des performances futures.

Berlin’s calling! 🇩🇪 2 days of in-depth discussions at the GIIN Impact Forum 2025 (The Global Impact Investing Network), to challenge practices and talk about impact without pretence. Eurazeo Planetary Boundaries Fund team from Eurazeo —, Erwann Le Ligné, Wilfried Piskula, Audrey LAMBRY — shared a clear belief: impact should be measured not by intention, but by outcomes. EPBF targets best buyout performance while contributing to the sovereignty and resilience of our societies and the economy.   That’s the spirit of EPBF: profitable companies delivering proven environmental solutions.   Elvina K. Johann-Felix Herter Sophie Flak, Caroline Flaissier, Benoit DESSOLAIN, Claire Berthoux, Léa Le Berre, Mathéo JAGOT, Axel de Robillard, Elie Cohen, Marième Diack

Europe is changing scale. With ELTIF 2.0, a new generation of investors can now access private markets and directly contribute to financing the real economy.   In this context, Eurazeo is launching PRIME, a new range of paneuropean evergreen funds: ➡️ EPIC, dedicated to private debt ➡️ EPSO, focused on secondary private equity   2 complementary vehicles designed to offer investors diversification, long-term returns and visibility, while supporting the growth of Europe’s small and mid-sized companies. In this video, Amélie Dupraz, CFA and Agathe Bubbe explain why evergreen funds are emerging as a durable answer to the transformation of private markets - and how this approach can accelerate the reallocation of European savings towards the real economy.   📘 Read our full conviction paper: https://lnkd.in/esnhs_4y

130 participants, strong winds, a few falls, and plenty of energy: the Eurazeo 2025 triathlon did not disappoint! Each year, this event brings our teams together around what truly unites us: a shared drive, a taste for challenge and the strength of teamwork! Congratulations to everyone for another great edition! 👏